The global hemp market is growing rapidly, with the hemp CBD market projected to surpass $22 billion by 2022. In Europe, the current market size for CBD is around €450 million and a projected worth of $1.7 billion by 2023. CanX is well-positioned as a leader in the cannabinoid industry, with premium CBD products that can be tailored to meet today’s and tomorrow’s demands.
With a team of industry professionals and over 35 years of experience, CanX provides investors access to a portfolio of organic hemp strains, seeds, soil treatments, and harvesting techniques from seed to sale.
Invest In CanX Today.
At CanX, we invested in a team with more than 35 years of combined experience in the entire seed-to-sale process to ensure transparency, longevity, and innovation in the CBD industry.
CanX operates out of a 33,000 square foot pharmaceutical-grade production and storage facility. It is complete with state-of-the-art cannabinoid extraction equipment to produce a pure, safe, and premium CBD product. Our facility is built in accordance with EUGMP—good manufacturing practice in the European pharmaceutical industry.
We Have Answers.
CanX is dedicated to helping our customers build thriving CBD businesses. We’re here to streamline the wholesale process, and we offer customer service 24/7 to ensure that the job always gets done.